~~<i id='B4D393A619'><strike id='B4D393A619'><tt id='B4D393A619'><pre id='B4D393A619'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

hotspot

author：knowledge 2025-10-02 22:58:52 - browse：55

Damian Garde of STAT talks with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho at STAT in NYC. — Damian Garde of STAT, left, talked with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho about the GLP-1 weight loss market. Michelle C. Gevint for STAT

NEW YORK — Will the world actually soon spend $100 billion a year on the new obesity medicines?

Plenty of people in pharma and at the banks that invest in it seem to think so. Goldman Sachs, Barclays, BMO Capital Markets and Pfizer have all arrived at the glossy, cut-for-headline number for spending by around 2030.

Yet Jared Holz, a healthcare strategist at Mizuho, is skeptical.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Readout LOUD podcast: possible new ALS drug, artificial wombs

leisure time

focus

explore

focus

leisure time

Wikipedia

AstudyfromZiyadAl-Aly,clinicalepidemiologistatWashingtonUniversityinSt.Louis,showedthatvaccinationap

WSS

CDC's new outbreak response network to include Northeastern

How AI helped researchers track recovery from depression

What to know about Virgin Galactic's 1st mission taking paying customers to space

Readout LOUD podcast: possible new ALS drug, artificial wombs

CDC advisers recommend seasonal use of Pfizer RSV shot

Why are Kaiser Permanente staff considering a strike?

leisure time

hotspot

leisure time

New air purifier tech could be key to improving indoor air quality

Biotech lab space demand falls sharply

Activists slam private health insurers over coverage restrictions

Ukraine and a new approach to mental health in war

State Dept. review finds Biden bears some blame for Afghanistan failures

Why are Kaiser Permanente staff considering a strike?

Moonlake's readout produced a cash windfall. Risks remain

EpiPen alternative approval delay highlights citizen petition issue

How to save PrEP access — and even expand it

Readout LOUD podcast: possible new ALS drug, artificial wombs

focus

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

How to use technology to prevent future drug shortages

Ukraine and a new approach to mental health in war

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

Changes to biosimilar regulatory framework must prioritize patients

Readout LOUD podcast: possible new ALS drug, artificial wombs

explore

focus

leisure time

Wikipedia